Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001048477-23-000051
Filing Date
2023-12-05
Accepted
2023-12-05 16:59:08
Documents
3
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1701813536.html 4  
1 FORM 4 wk-form4_1701813536.xml 4 4915
2 EX-24 section16filingspowerofa.htm EX-24 3881
3 section16filingspowerofa001.jpg GRAPHIC 218858
  Complete submission text file 0001048477-23-000051.txt   311669
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901
Business Address
Guyer Charles Greg (Reporting) CIK: 0001811096 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 231467399